InsiderClue
← All stocks

CAPRICOR THERAPEUTICS, INC.

CAPR Net selling
CIK 0001133869 #3252 in the set updated 17 Sep 2026
Bought (120 mo)
$19.73M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$957.78M
$0.00 on a plan · $8.37M straight out of an exercise
Sold at will
$949.42M
4 of 17 sales
Net
−$938.05M
−$929.68M against sales at will

By person

14 insiders · 63 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Avat Xavier
Former CBO
$9.32K (2)
$949.23M (2)
−$949.22M
0
0.0000%
$0.00
−100.0%
Nippon Shinyaku Co Ltd entity
10% owner
$15.00M (1)
—
+$15.00M
7,090,351
12.20%
$215.40M
+65.2%
CEDARS SINAI MEDICAL CENTER
10% owner
$4.55M (2)
—
+$4.55M
4,049,959
6.97%
$123.04M
+56.2%
Sabar Karimah Es
Director
—
$3.76M (3) scheduled
−$3.76M
0
0.0000%
$0.00
—
Bergmann Anthony
CHIEF FINANCIAL OFFICER
—
$2.30M (5) scheduled
−$2.30M
11,223
0.0193%
$340.95K
+5,429%
Krasney Karen
EVP, GENERAL COUNSEL
—
$2.30M (5) scheduled
−$2.30M
30,547
0.0525%
$928.02K
+2,640%
Musket David B
Director
$100.21K (4)
$185.29K (2)
−$85.08K
88,788
0.1527%
$2.70M
—
Manzo Louis
Director
$31.00K (1)
—
+$31.00K
125,962
0.2167%
$3.83M
+157.2%
COLLIER EARL M JR
Director
$28.30K (1)
—
+$28.30K
57,606
0.0991%
$1.75M
—
Auwaerter Paul Gisbert
Director
$14.20K (1)
—
+$14.20K
5,000
0.0086%
$151.90K
—
Marban Linda
CHIEF EXECUTIVE OFFICER
—
—
—
521,019
0.8962%
$15.83M
+12.8%
Litvack Frank
Director
—
—
—
180,054
0.3097%
$5.47M
—
Smith Rachel
Vice President of R&D
—
—
—
18,504
0.0318%
$562.15K
—
DUNBAR GEORGE W JR
Director
—
—
—
14,306
0.0246%
$434.62K
—

Individual transactions

34
Insider
Date
Role
Action
Shares
Price
Amount
Bergmann Anthony
18 May 2026
CHIEF FINANCIAL OFFICER
Exercised, kept
3,000
$1.39
$4.17K
Litvack Frank
13 May 2026
Director
Exercised, kept
3,937
$1.39
$5.47K
Krasney Karen
30 Dec 2025
EVP, GENERAL COUNSEL
Exercised, kept
2,500
$1.39
$3.48K
DUNBAR GEORGE W JR
19 Dec 2025
Director
Exercised, kept
3,000
$1.39
$4.17K
DUNBAR GEORGE W JR
3 Mar 2025
Director
Exercised, kept
750
$1.39
$1.04K
Litvack Frank
3 Mar 2025
Director
Exercised, kept
25,000
$1.39
$34.75K
Bergmann Anthony
3 Mar 2025
CHIEF FINANCIAL OFFICER
Exercised, kept
2,500
$1.39
$3.48K
Marban Linda
3 Mar 2025
CHIEF EXECUTIVE OFFICER
Exercised, kept
25,000
$1.39
$34.75K
COLLIER EARL M JR
27 Feb 2025
Director
Exercised, kept
750
$1.39
$1.04K
Krasney Karen
13 Dec 2024
EVP, GENERAL COUNSEL
Exercised, kept
8,000
$1.39
$11.12K
Litvack Frank
3 Dec 2024
Director
Exercised, kept indirect
20,391
$1.10
$22.43K
Musket David B
7 Aug 2024
Director
Exercised, kept
34,000
$1.39
$47.26K
Musket David B
23 Apr 2024
Director
Exercised, kept
16,156
$1.39
$22.46K
COLLIER EARL M JR
23 Apr 2024
Director
Exercised, kept
30,000
$1.39
$41.70K
Bergmann Anthony
23 Oct 2023
CHIEF FINANCIAL OFFICER
Exercised, kept
2,178
$1.39
$3.03K
Litvack Frank
14 Aug 2023
Director
Exercised, kept
20,748
$1.39
$28.84K
Marban Linda
12 May 2023
CHIEF EXECUTIVE OFFICER
Exercised, kept
20,749
$1.39
$28.84K
Avat Xavier
5 Apr 2023
FORMER CHIEF BUSINESS OFFICER
Exercised, kept
84,791
$3.46
$293.38K
Litvack Frank
21 Feb 2023
Director
Exercised, kept
14,027
$1.39
$19.50K
Manzo Louis
21 Feb 2023
Director
Exercised, kept
1,401
$1.39
$1.95K
COLLIER EARL M JR
14 Feb 2023
Director
Exercised, kept
1,401
$1.39
$1.95K
DUNBAR GEORGE W JR
14 Feb 2023
Director
Exercised, kept
1,401
$1.39
$1.95K
Krasney Karen
3 Nov 2022
EVP, GENERAL COUNSEL
Exercised, kept
18,932
$1.39
$26.32K
Musket David B
30 Jun 2022
Director
Exercised, kept
10,796
$1.39
$15.01K
Manzo Louis
31 Mar 2022
Director
Exercised, kept
27,904
$1.39
$38.79K
DUNBAR GEORGE W JR
29 Mar 2022
Director
Exercised, kept
15,455
$1.39
$21.48K
COLLIER EARL M JR
8 Mar 2022
Director
Exercised, kept
15,455
$1.39
$21.48K
Litvack Frank
3 Jan 2022
Director
Exercised, kept
154,543
$1.39
$214.81K
Musket David B
27 Dec 2021
Director
Exercised, kept
20,391
$1.10
$22.43K
Musket David B
27 Dec 2021
Director
Exercised, kept
15,455
$1.39
$21.48K
Manzo Louis
24 Sep 2020
Director
Exercised, kept
8,299
$3.70
$30.71K
Marban Linda
27 Jul 2020
CHIEF EXECUTIVE OFFICER
Exercised, kept
41,497
$3.70
$153.54K
Smith Rachel
22 Dec 2017
Vice President of R&D
Exercised, kept
20,748
$0.16
$3.32K
Manzo Louis
23 Oct 2017
Director
Exercised, kept
20,748
$0.16
$3.32K
Show all 63 transactions →

What was left out

Form 4 filings counted 169
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 13
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 1,226,406
Sales filed before the plan box existed 2
History held since 22 Sep 2016